Naloxegol
Clinical data | |
---|---|
Trade names | Movantik |
AHFS/Drugs.com | movantik |
[[Regulation of therapeutic goods |Template:Engvar data]] | |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | ~4.2% |
Metabolism | Hepatic (CYP3A) |
Elimination half-life | 6–11 h |
Excretion | Feces (68%), urine (16%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEBI | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C34H53NO11 |
Molar mass | 651.785 |
3D model (JSmol) | |
| |
|
WikiDoc Resources for Naloxegol |
Articles |
---|
Most recent articles on Naloxegol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Naloxegol at Clinical Trials.gov Clinical Trials on Naloxegol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Naloxegol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Naloxegol Discussion groups on Naloxegol Directions to Hospitals Treating Naloxegol Risk calculators and risk factors for Naloxegol
|
Healthcare Provider Resources |
Causes & Risk Factors for Naloxegol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Naloxegol (INN; NKTR-118), or PEGylated naloxol,[1] trade name Movantik, is a peripherally-selective opioid antagonist under development by AstraZeneca, licensed from Nektar, for the treatment of opioid-induced constipation.[2]
See also
References
- ↑ Roland Seifert; Thomas Wieland; Raimund Mannhold (17 July 2006). G Protein-Coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity. John Wiley & Sons. p. 227. ISBN 978-3-527-60695-5. Retrieved 14 May 2012. Unknown parameter
|coauthors=
ignored (help) - ↑ "Nektar | R&D Pipeline | Products in Development | CNS/Pain | Oral Naloxegol (NKTR-118) and Oral NKTR-119". Retrieved 2012-05-14.
- Pages with script errors
- Pages with citations using unsupported parameters
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs
- Alkenes
- Diols
- Morphinans
- Opioid antagonists
- Synthetic opioids